Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density lipoprotein levels.

Metabolism: clinical and experimental

Volumn 51, Issue 11, 2002, Pages 1410-1417

  Ulloa, Natalia ^a   Arteaga, Eugenio ^a   Bustos, Paulina ^a   Durán Sandoval, Daniel ^a   Schulze, Kim ^a   Castro, Graciela ^a   Jauhiainen, Matti ^a   Fruchart, Jean Charles ^a   Calvo, Carlos ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; MEDROXYPROGESTERONE;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; ESTROGEN THERAPY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPIDS; MEDROXYPROGESTERONE; MIDDLE AGED; POSTMENOPAUSE;

EID: 0036834590     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.35580     Document Type: Article

References (0)